PEOPLE ON THE MOVE

People ON THE MOVE Insight's monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and personnel changes, nationally and globally.

RANZCO FINDS NEXT CEO TO REPLACE DAVID ANDREWS Mr Mark Carmichael has been appointed as the new CEO of RANZCO, effective 16 May. He previously served 10 years as CEO of the Australian Society of Anaesthetists – and prior to that CEO of the Australian Society of Otolaryngology Head and Neck Surgeons for five years. He holds a Bachelor of Health Science – Physical Education from the University of WA and a Masters in Business Management from the University of Technology, Sydney. He is looking forward to working with the RANZCO Board and staff to build on the strategic direction of the college and the specialty at large.

CORE EXPANDS SPECIALTY CONTACT LENS EXPERTISE The Centre for Ocular Research & Education (CORE) has appointed Dr Rosa Yang as a Clinical Research Associate, supporting the growing use of specialty contact lenses worldwide. Yang also serves as a Clinical Instructor at the University of Waterloo School of Optometry & Vision Science and is a practising optometrist. Her cornea and contact lens residency at the University of Waterloo focused on managing patients exhibiting corneal ectasia and severe dry eye with specialty contact lenses, as well as myopia control therapies, including orthoK. PROFESSOR STEPHANIE WATSON JOINS SYDNEY NANO FIRM Save Sight Institute’s Professor Stephanie Watson is starting a new position as Co-Deputy Director of Industry, Innovation and Commercialisation at The University of Sydney Nano Institute. Watson is Chair of the Ophthalmic Research Institute of Australia, Editor for the Cochrane Eyes and Vision, and Regenerative Medicine Theme Leader for Stem Cells Australia. She has appointments at the Sydney Eye Hospital, Sydney Children’s Hospital and Prince of Wales Hospital. Watson specialises in the anterior segment and is known for groundbreaking research in corneal stem cell treatment. VISIONEERING TECHNOLOGIES APPOINTS NEW CHIEF MEDICAL OFFICER ASX-listed Visioneering Technologies has named Dr Kuang-mon (Ashley) Tuan as its new Chief Medical Officer. Tuan will be responsible for managing clinical research studies, such as the NaturalVue (etafilcon A) Multifocal randomised clinical trial for myopia control in children, helping identify and develop new products, and leading efforts to communicate findings in journals and scientific meetings. She will also lead a Professional Services team as it communicates technical information to eyecare professionals. Image: Ohio State University.

MEDMONT INTERNATIONAL FINDS NEW MARKETING MANAGER Ms Marcelle Nadler, who has previously practised as an optometrist, announced she has started a new position as Senior Product Marketing Manager at Medmont International Pty Ltd where she will be heading up marketing. She recently finished her (remote) Product Marketing Manager role at NikonEssilor after year-long border closures meant she couldn’t make the move to Tokyo for the job. “I look forward to this new role at Medmont where I can once again combine my passions of marketing, optometry and strategy,” she said. Image: Linkedin ESSILORLUXOTTICA MAKES CHANGES AT GRANDVISION EssilorLuxottica has announced a leadership reshuffle of newly acquired optical retail giant GrandVision. Mr Massimiliano Mutinelli (pictured ©Alberto Calcinai per Vision.biz) has become President of Optical Retail for EMEA at EssilorLuxottica and Head of Amsterdam corporate offices at GrandVision, replacing GrandVision CEO Mr Stephan Borchert. Mr Niccolò Bencivenni has become Chief Financial Officer, replacing Mr Willem Eelman, effective 22 April.